23 -
25
March
Wednesday
Accelerating drug discovery with Systems Biology and Artificial Intelligence
We decipher drug effects on cellular signaling – one of the least understood aspects of biology, and a major point of failure for new medicines. We provide unique tools for discovery and optimization of GPCR drug candidates.
The InterAx platfrom
InterAx helps partners to accelerate and optimize hit‑to‑lead identification for GPCRs.
With Support From
Previous
Next
Featured News
SEP 2021
Early and successful completion of European Union’s H2020 Project September 2021, Switzerland Today, InterAx Biotech AG, a Biotech…
APR 2021
InterAx Biotech further strengthens its Scientific Advisory Board – welcoming Prof. Dr. Ruedi Aebersold as a member April 2021,…
APR 2020
A Spanish-Swiss Liaison to fight COVID-19
